
Expert in complex oncological surgery Melanoma, sarcoma and rare tumors
Surgical oncologyקרן
, תל אביב
03/23/2026
Automatic translation
David
, Modiin
11/11/2025
Automatic translation
אורי
, הרצליה
11/10/2025
Automatic translation
Position
Senior physician in the Department of Oncological Surgery at Hadassah Ein Kerem Hospital, Jerusalem
License ID
141375
Speciality
Oncological Surgery - Melanoma, Sarcoma and Rare Tumors
Other Specialties
Soft tissue tumors, complex surgeries for metastasis removal in limbs and soft tissues, complex tissue reconstructions using skin flaps, metastatic melanoma, metastatic sarcoma, NET tumors.
Description
Dr. Meni Brakha, an oncological surgeon specializing in melanoma and sarcoma operations, leads the melanoma and sarcoma surgery department at Hadassah Ein Kerem as part of a broad multidisciplinary team. A graduate of official fellowship training at Peter MacCallum Cancer Centre (Australia) and training at Moffitt Cancer Center in Tampa, USA. An expert in wide excisions of melanoma and advanced reconstructions (oncoplastics), sentinel lymph node biopsy, extensive lymph node dissection, excision of soft tissue tumors and sarcomas throughout the body (including retroperitoneum, limb-sparing surgeries, and advanced local treatments such as isolated limb perfusion chemotherapy in cases of metastatic melanoma or attempts to preserve limbs in sarcoma diagnosis. Performs all surgical components personally with emphasis on human and empathetic treatment, aspiration for optimal oncological healing and reduction of complication risk as much as possible.
Professional Experience
Senior physician in the oncological surgery department at Hadassah Ein Kerem Hospital, Jerusalem
Extended specialization in oncological surgery, with emphasis on melanoma, sarcoma and rare tumors at one of the leading cancer centers in the world - Peter MacCallum Cancer Center in Melbourne, Australia.
Training in oncological surgery at Moffitt Cancer Center in Tampa, Florida, USA.
Specialization in general surgery at Ichilov Hospital
Engagement in laboratory research in the field of oncological surgery, and partner in several international clinical research initiatives in the field of melanoma and sarcoma.
Permanent panel member in a global forum for discussion of complex sarcoma cases
Manager of sarcoma forum for questions on complex cases - https://www.doctors.co.il/forum-6382
Education
Medical studies at the Hebrew University of Jerusalem
Membership
Australian College of Surgeons
American Society of Surgical Oncology - SSO
American Society of Clinical Oncology - ASCO
Sentinel Lymph Node Working Group
European Society for Medical Oncology - ESMO
TARPSWG - World Association of Sarcoma Surgery Specialists
Surgeons Association
Israeli Association for Melanoma and Skin Cancer
Languages
Hebrew
English
Treatments
Cutaneous melanoma – diagnosis and surgery: wide excision, skin reconstruction (oncoplastics), sentinel lymph node biopsy, margin management.
Melanoma with lymph node involvement - radical lymph node dissection.
Sarcomas (limb/body/Retroperitoneal): surgical planning for limb/organ preservation.
Retroperitoneal Sarcoma.
Rare skin tumors (Merkel/DFSP/NMSC high-risk) and rare soft tissue tumors.
Dermatofibrosarcoma - DFSP.
Desmoid fibromatosis - Desmoid Tumor.
Kaposi sarcoma - lesion excision, intratumoral chemotherapy injection as an alternative to intravenous chemotherapy.
Breast phyllodes tumor - clinical and imaging assessment, precise surgical planning, personalized surgeries with aesthetic considerations.
Metastatic melanoma - treatment of in-transit metastases and soft tissue metastases.
Isolated Limb Infusion - infusion of chemotherapy to the limb only for limb preservation in cases of metastatic melanoma in the limb or limb sarcoma.
Second opinion before surgery or after partial/incomplete surgery in the field of melanoma and sarcoma.
Surgeries
Melanoma Surgery - Malignant Melanoma
Wide excision of melanoma with complex reconstructions when required for excellent cosmetic results (oncoplastics).
Sentinel lymph node biopsy, with precise localization and identification of the lymph node, in an attempt to improve disease control and refine treatment.
Radical lymphadenectomy
In-transit melanoma resection.
Robotic pelvic lymphadenectomy.
Skin flaps for reconstruction (alternative to skin graft with significantly better cosmetic results and fewer complications compared to grafts).
Primary biopsy of suspicious lesions in skin and soft tissues.
Surgery for resection of melanoma metastases in internal organs.
Consultation and second opinion for complex cases with primary or metastatic disease.
Complex surgeries for other skin tumors.
Axillary dissection/lymphadenectomy, specialized surgery for melanoma with involvement of deep lymph nodes (element not performed in lymph node surgery for breast cancer).
Inguinal lymphadenectomy/groin dissection - complex surgery with removal of all lymph nodes in the groin in one block, attempting to minimize the chances of local/regional disease recurrence.
Pelvic lymphadenectomy - performing the surgery both through open approach and robotically, decision made for each individual case with attempt for maximal control of regional disease.
Resection of melanoma metastases for production of personalized autologous vaccine in cases of inability to receive immunotherapy, and after discussion and evaluation by our comprehensive melanoma team.
Neck dissection of lymph nodes in cases of metastatic melanoma in cervical lymph nodes, when indicated.
Surgery for resection of hepatic metastases of uveal melanoma.
Sarcoma surgeries - Soft Tissue Sarcoma
Resection of retroperitoneal sarcoma - tailoring specific surgery to the precise sarcoma subtype, with attempt to preserve organs without oncological compromise.
Resection of dermatofibrosarcoma protuberans (DFSP) throughout the body, with optimal oncological outcomes and emphasis on cosmetic aspects.
Desmoid tumor surgeries - meticulous assessment of disease status, often healing without any surgery, desmoid surgeries when indicated with attention to cosmetic elements.
Cutaneous sarcomas of the scalp, head and neck - surgeries for Pleomorphic Dermal Sarcoma and other cutaneous sarcomas such as Leiomyosarcoma.
Metastatic sarcoma in the abdominal cavity - especially after unsuccessful primary surgery performed previously, with attention to disease biology and meticulous assessment in attempt to achieve cure when possible.
Isolated Limb Infusion of chemotherapy in minimally invasive approach, for limb preservation in cases of limb sarcoma requiring amputation.
Angiosarcoma surgeries, including cases of radiation-induced angiosarcoma.
Breast phyllodes tumor - complete assessment before surgery, tailoring the required surgical type to tumor grade, breast-conserving surgeries and oncoplasty.
Liposarcoma/Atypical Lipomatous Tumor - surgeries for liposarcoma tumors throughout the body, including extremities, chest, abdominal wall. Limb-sparing surgeries, with local cosmetic reconstructions (oncoplasty).
GIST surgeries - surgeries for both primary tumor and metastatic disease when control cannot be achieved at disease site with drug therapy.
Retroperitoneal Leiomyosarcoma - extensive experience in complex surgeries for leiomyosarcoma resection, sometimes requiring resection of major blood vessels to achieve cure and vascular reconstruction with grafts. Surgeries are performed as part of the comprehensive sarcoma team with full interdisciplinary cooperation to achieve optimal results.
Kaposi Sarcoma - surgeries for sarcoma and lesion resection when indicated, alternatively local injection of chemotherapy into the tumor (without systemic effects) with excellent results.
Initial assessment and thorough investigation of new soft tissue mass appearance - targeted imaging, decision on biopsy method, expediting investigation when necessary and building personalized treatment and surgical plan.
Surgeries for benign lipomas and advanced lipomas, including complex cases.
Merkel Cell Carcinoma - Merkel Cell Carcinoma
Evaluation of Merkel cell tumor - sometimes the decision that surgery is not necessary with identical chances of healing, sometimes the need for tumor removal.
Sentinel lymph node sampling in Merkel cell carcinoma - a critical element in treatment with the need for accurate identification of the lymph node, for the purpose of deciding on radiation delivery to the lymph node area in order to control the disease and prevent its progression.
Surgeries for metastases of Merkel cell carcinoma, mainly along the limbs but also in soft tissues.
Surgery for Peripheral Nerve Tumors - Peripheral Nerve Tumors
Assessment and analysis directed at Malignant Peripheral Nerve Sheath Tumor (MPNST).
Wide excision of neural tumors with neurovascular preparation.
Surgery for schwannoma tumors.
Surgery for neurofibroma and neurofibromatosis tumors.
Surgery for perineurioma tumors.
Surgery for granular cell tumors.
Surgery for rare non-melanoma skin tumors - Non-Melanoma Rare Skin Cancers
Surgery for Porocarcinoma tumor.
Surgery for Adnexal Skin Tumors and hair follicle tumors.
Surgery for Sebaceous Carcinoma.
Surgery for advanced Squamous Cell Carcinoma.
Surgery for rare cutaneous sarcomas including Pleomorphic Dermal Sarcoma and Undifferentiated Pleomorphic Sarcoma.
Surgery for Retroperitoneal Sarcoma - Retroperitoneal Sarcoma
Planned multivisceral resections.
Margin planning and organ-sparing procedures depending on the specific biology of the disease and individualized treatment plan.
Combined surgeries with major vascular resections and vascular reconstructions.
Surgeries for retroperitoneal liposarcoma.
Surgeries for retroperitoneal leiomyosarcoma.
Surgeries for retroperitoneal solitary fibrous tumor.
Surgeries for small round blue cell tumors of the retroperitoneum.
Surgeries for malignant peripheral nerve sheath tumor.
Surgeries for all malignant and benign tumors of the retroperitoneum.
Surgery for metastatic retroperitoneal sarcoma.
Locations
* You can also schedule an appointment at the clinic by calling 02-6778899
* You can also schedule an appointment at the clinic by calling 02-6778899
Media
In full arrangement with all insurance companies and all health funds (Shaban)

How to identify the rare cancer sarcoma before it is too late?

From a patient conference of the Israeli Skin Cancer Association and the Sharett Institute of Oncology at Hadassah Ein Kerem Medical Center.
As a surgeon specializing in melanoma treatment, I see great importance in raising awareness about this disease. Melanoma is a dangerous type of skin cancer that develops in melanocyte cells - the cells responsible for producing pigment in the skin
Retroperitoneal sarcoma is a rare type of cancer that develops in the retroperitoneum, an area in the abdomen located behind the peritoneum, the tissue that lines the abdominal cavity. The retroperitoneum contains several vital organs, including the kidneys, pancreas, and major blood vessels. Due to its location, tumors in this area can grow to very large dimensions before they cause noticeable symptoms.
Your trust is the most important thing so doctors can not pay to change or delete the review.
Overall rating of Dr. Meni Brakha
5.0Based on 116 reviews
Show by medical issue or treatment type
יאיר לורברבוים
, ירושלים
07/13/2026
Automatic translation
שלמה
, ירושלים
07/12/2026
Automatic translation
יפית
, שרעבי
07/12/2026
Automatic translation
Suri Ordman
, Jerusalem
07/12/2026
ד"ר יפעת לב ארי
, מכבים
07/12/2026
Automatic translation
ד"ר אורי ארני
, באר יעקב
06/30/2026
Automatic translation
קרול
, אשדוד
05/29/2026
Automatic translation
אזולאי
, ירושלים
05/28/2026
Automatic translation
Debra Markus
, Jerusalem
05/28/2026
גדי אילון
, באר טוביה
05/26/2026
Automatic translation
Sentinel lymph node biopsy checks whether melanoma cells have spread to the first lymph node draining the tumour area. It is usually performed when melanoma thickness exceeds ~0.8 mm, or in thinner melanomas with ulceration or high-risk features. The procedure is used for staging and guiding further treatment. Surgery is performed together with wide local excision, usually under general anaesthesia, using lymphoscintigraphy and a dye/tracer.
Retroperitoneal sarcomas are situated close to vital organs (kidney, pancreas, bowel, major vessels). Multivisceral resection planning is often required, sometimes including adjacent organ removal to achieve clear margins. Decisions are made by an experienced retroperitoneal sarcoma MDT, with advanced imaging and surgery performed by a sarcoma surgeon well versed in oncological pathways. Choosing a high-volume centre reduces complications and improves local control and survival.
When a diagnosis emerges after unplanned excision, re-mapping is required: complete pathology, appropriate imaging (MRI/CT/PET as needed) and MDT discussion. In melanoma — margin widening and SLNB may be needed to complete staging. In sarcoma — planned re-resection along the correct oncological pathway to achieve negative margins is usually required, sometimes with adjuvant treatment. The goal: correct the oncological pathway and minimise local/systemic recurrence risk.
Look for dedicated experience (high annual surgical volume), an academic multidisciplinary centre and the ability to perform the full treatment sequence: correct diagnosis (biopsy/mapping), precise surgery (wide margins/SLNB/multivisceral) and oncoplastic reconstruction when needed. Ask who actually performs all stages of surgery, how many similar cases are done per year and what the complication and re-resection rates are.
The follow-up programme is determined according to disease stage/histology and includes periodic clinical examination, lymph node ultrasound in selected melanomas, and imaging (CT/MRI/PET) in sarcomas according to recurrence/metastasis risk. Warning signs: new/growing lump, change in scar, lymph node swelling, deep/persistent pain, unexplained weight loss, new/persistent cough. Rapid reporting to the team enables early diagnosis and optimal treatment.
ILI or ILP are regional treatment procedures for in-transit melanoma or multiple limb lesions not amenable to simple excision or insufficiently responsive to systemic treatment. Blood flow to the limb is isolated briefly and a high-concentration chemotherapy drug is infused through catheters, achieving high local response while minimising systemic exposure. Goals: limb preservation, disease burden reduction and quality-of-life improvement.
Effective systemic treatments (immunotherapy, targeted therapy) are now given before/after surgery according to disease stage. In selected situations neo-adjuvant therapy is considered to reduce disease/improve outcomes, and in other stages adjuvant therapy is used to reduce recurrence risk. The decision requires a multidisciplinary team that understands the timing relative to surgery (wound risks, side effects, immune toxicity).
Not always. A desmoid tumour (Aggressive fibromatosis) is a connective tissue tumour with locally aggressive behaviour, but unlike classic sarcoma it does not metastasise. In many cases the first recommendation is close monitoring (active surveillance) because some tumours stabilise or even shrink without surgery. When there is severe pain, functional impairment, risk of nerve/vascular damage or threatening growth, active treatment is discussed: planned surgery preserving function, or dedicated targeted/biological therapy. Most importantly: do not rush to 'over-wide' surgery with a non-specialist surgeon, as aggressive excision can cause major functional damage without oncological benefit.
DFSP is a soft-tissue skin/subcutaneous tumour considered locally aggressive but with a relatively low tendency to metastasise. The main problem with DFSP is microscopic roots that can extend far beyond what is visible. Wide excision with correct margins is therefore critical. A common mistake is small cosmetic excision in the community, which returns DFSP pathology — requiring planned re-resection at a sarcoma centre, sometimes with oncoplastic reconstruction. The goal: remove all DFSP with clean margins (R0) and prevent local recurrence.
Some Israeli services use a multidisciplinary model where different stages are performed by different teams, and this is certainly a valid option. However, there is also an approach where a single oncological surgeon expert in melanoma performs the entire surgical sequence. This is standard practice at many leading cancer centres worldwide. Potential advantages include unified oncological planning, a single point of clinical responsibility, fewer handoffs between teams, tailored oncoplastic reconstruction and simplified follow-up communication.
Wide local excision alone can be performed under local anaesthesia only (sometimes combined with sedation). When sentinel node biopsy is also required, surgery is usually performed under general anaesthesia, though in some cases sedation is sufficient. Regarding hospitalisation, Dr Meni Bercha routinely discharges patients home on the day of surgery provided they feel well and wish to be discharged. He remains personally available at all times and maintains ongoing contact with his patients.
The margin removed around a melanoma is determined by the Breslow thickness. For in-situ melanoma 5 mm margins are required; for thin melanoma 1 cm; for thick melanomas usually 2 cm. The goal is optimal local control without unnecessary functional or aesthetic compromise. In sensitive locations (face, hand/foot, ear) oncoplastic planning is required.
Today, complete lymph node dissection is not the default in every positive case. In many cases the preference is careful surveillance with periodic ultrasound of the lymphatic region and consideration of adjuvant immunotherapy according to stage and tumour characteristics. This reduces lymphoedema complications without compromising oncological outcomes.
Metastatic melanoma does not always mean there is no surgical option. There are two main arms: advanced systemic treatments (immunotherapy and targeted therapy) that can achieve disease control or even disappearance of certain metastases; and focused oncological surgery — in selected cases with isolated lesion(s) or limited disease burden, complete surgical removal can be considered as part of the overall treatment.
For any deep mass over 5 cm or rapidly growing mass, sarcoma should be suspected and MRI performed for precise assessment of extent and involvement of muscles, nerves and vessels. Core-needle biopsy must be performed by a coordinated sarcoma team, along a tract that can be excised in future surgery — to avoid unplanned excision which increases recurrence risk. After diagnosis, a Tumour Board determines the strategy: surgery to negative margins with/without radiation/chemotherapy according to histology, grade and location.
You can contact Dr. Meni Brakha by phone: 055-4561351.
The clinic of Dr. Meni Brakha specializes in Surgical oncology, Oncology, Dermatology Malignant Lesions, Orthopedic Oncology.
Dr. Meni Brakha provides service in the following languages: Hebrew, English.
You can contact Dr. Meni Brakha by email.
You can book an appointment with Dr. Meni Brakha via 055-4561351 or by email.
You need to contact the clinic of Dr. Meni Brakha to find out.
The service provided through the website is not a medical service. Documentation and sensitive information should only be given to doctors.
About
MedReviews is Israel's most advanced and reliable doctor index, centralizing information and verified reviews on doctors and clinics. Part of Israel's leading review site group, we connect patients seeking quality medical care with top recommended doctors. We achieve this through rigorous verification technology ('crowd wisdom') and advanced filtering mechanisms, providing full transparency in the medical world and enabling informed choices.
Navigation
Contact UsAboutPrivacy PolicyTerms of ServiceAccessibilityMedical articlesPhoto GalleryList your practice on MedReviewsLog inSpecialist Doctors
GynecologistsOrthopedistsOphthalmologistsPlastic SurgeonsDermatologistsCardiologistsENT DoctorsPsychiatristsGeneral SurgeonsOncologistsAesthetic MedicineDentistsDisclaimer
The information and content displayed on this site is intended to provide informative information and expressive opinion on behalf of third parties only they are not a substitute for professional medical advice and should not be relied upon as such advice. Any use of the information on the site requires examination and verification with the relevant parties. Use of the site and its contents is the sole and complete responsibility of the user